Hyperlipoproteinemia medical therapy: Difference between revisions
Jump to navigation
Jump to search
Hardik Patel (talk | contribs) No edit summary |
Hardik Patel (talk | contribs) No edit summary |
||
| Line 9: | Line 9: | ||
===Medical Therapy in Children and Adolescents=== | ===Medical Therapy in Children and Adolescents=== | ||
*[[Hyperlipidemia NCEP recommendations for drug therapy of high-risk hyperlipidemia in children and adolescents | Drug therapy | *[[Hyperlipidemia NCEP recommendations for drug therapy of high-risk hyperlipidemia in children and adolescents | Drug therapy]] | ||
*[[Hyperlipidemia statins in children and adolescents with hyperlipidemia | Statins | **[[Hyperlipidemia statins in children and adolescents with hyperlipidemia | Statins]] | ||
*[[Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents | Adjuvant therapies]] | *[[Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents | Adjuvant therapies]] | ||
Revision as of 17:16, 26 October 2012
|
Lipoprotein Disorders Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]